nodes	percent_of_prediction	percent_of_DWPC	metapath
Flucloxacillin—CYP3A4—Everolimus—kidney cancer	0.198	0.293	CbGbCtD
Flucloxacillin—CYP3A4—Temsirolimus—kidney cancer	0.134	0.198	CbGbCtD
Flucloxacillin—CYP3A4—Pazopanib—kidney cancer	0.0703	0.104	CbGbCtD
Flucloxacillin—CYP3A4—Erlotinib—kidney cancer	0.0502	0.0741	CbGbCtD
Flucloxacillin—CYP3A4—Paclitaxel—kidney cancer	0.0459	0.0678	CbGbCtD
Flucloxacillin—CYP3A4—Sorafenib—kidney cancer	0.0408	0.0603	CbGbCtD
Flucloxacillin—CYP3A4—Vinblastine—kidney cancer	0.0403	0.0595	CbGbCtD
Flucloxacillin—CYP3A4—Vincristine—kidney cancer	0.0396	0.0585	CbGbCtD
Flucloxacillin—CYP3A4—Sunitinib—kidney cancer	0.0331	0.0488	CbGbCtD
Flucloxacillin—CYP3A4—Doxorubicin—kidney cancer	0.0248	0.0366	CbGbCtD
Flucloxacillin—Candida infection—Doxorubicin—kidney cancer	0.000524	0.00162	CcSEcCtD
Flucloxacillin—Abdominal pain—Vinblastine—kidney cancer	0.000523	0.00162	CcSEcCtD
Flucloxacillin—Headache—Pazopanib—kidney cancer	0.000523	0.00162	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000521	0.00161	CcSEcCtD
Flucloxacillin—Body temperature increased—Everolimus—kidney cancer	0.000521	0.00161	CcSEcCtD
Flucloxacillin—Abdominal pain—Everolimus—kidney cancer	0.000521	0.00161	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Erlotinib—kidney cancer	0.00052	0.00161	CcSEcCtD
Flucloxacillin—Urinary tract disorder—Paclitaxel—kidney cancer	0.000514	0.00159	CcSEcCtD
Flucloxacillin—Connective tissue disorder—Paclitaxel—kidney cancer	0.000512	0.00158	CcSEcCtD
Flucloxacillin—Leukopenia—Vincristine—kidney cancer	0.000511	0.00158	CcSEcCtD
Flucloxacillin—Urethral disorder—Paclitaxel—kidney cancer	0.00051	0.00158	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Dactinomycin—kidney cancer	0.00051	0.00158	CcSEcCtD
Flucloxacillin—Dyspepsia—Sorafenib—kidney cancer	0.000504	0.00156	CcSEcCtD
Flucloxacillin—Abdominal pain—Erlotinib—kidney cancer	0.000503	0.00156	CcSEcCtD
Flucloxacillin—Body temperature increased—Erlotinib—kidney cancer	0.000503	0.00156	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Gemcitabine—kidney cancer	0.000502	0.00155	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000502	0.00155	CcSEcCtD
Flucloxacillin—Anaemia—Gemcitabine—kidney cancer	0.0005	0.00155	CcSEcCtD
Flucloxacillin—Neutropenia—Capecitabine—kidney cancer	0.000499	0.00154	CcSEcCtD
Flucloxacillin—Decreased appetite—Sorafenib—kidney cancer	0.000497	0.00154	CcSEcCtD
Flucloxacillin—Nausea—Pazopanib—kidney cancer	0.000496	0.00153	CcSEcCtD
Flucloxacillin—Convulsion—Vincristine—kidney cancer	0.000494	0.00153	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000494	0.00153	CcSEcCtD
Flucloxacillin—Erythema multiforme—Paclitaxel—kidney cancer	0.000492	0.00152	CcSEcCtD
Flucloxacillin—Constipation—Sorafenib—kidney cancer	0.000489	0.00151	CcSEcCtD
Flucloxacillin—Malaise—Gemcitabine—kidney cancer	0.000488	0.00151	CcSEcCtD
Flucloxacillin—Hypersensitivity—Vinblastine—kidney cancer	0.000488	0.00151	CcSEcCtD
Flucloxacillin—Myalgia—Vincristine—kidney cancer	0.000486	0.0015	CcSEcCtD
Flucloxacillin—Hypersensitivity—Everolimus—kidney cancer	0.000486	0.0015	CcSEcCtD
Flucloxacillin—Dyspepsia—Sunitinib—kidney cancer	0.000485	0.0015	CcSEcCtD
Flucloxacillin—Leukopenia—Gemcitabine—kidney cancer	0.000485	0.0015	CcSEcCtD
Flucloxacillin—Decreased appetite—Sunitinib—kidney cancer	0.000479	0.00148	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000475	0.00147	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000475	0.00147	CcSEcCtD
Flucloxacillin—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.000472	0.00146	CcSEcCtD
Flucloxacillin—Constipation—Sunitinib—kidney cancer	0.000471	0.00146	CcSEcCtD
Flucloxacillin—Immune system disorder—Paclitaxel—kidney cancer	0.00047	0.00146	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Sorafenib—kidney cancer	0.000468	0.00145	CcSEcCtD
Flucloxacillin—Renal failure—Capecitabine—kidney cancer	0.000468	0.00145	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Vincristine—kidney cancer	0.000466	0.00144	CcSEcCtD
Flucloxacillin—Jaundice—Capecitabine—kidney cancer	0.000464	0.00144	CcSEcCtD
Flucloxacillin—Arthralgia—Gemcitabine—kidney cancer	0.000461	0.00143	CcSEcCtD
Flucloxacillin—Myalgia—Gemcitabine—kidney cancer	0.000461	0.00143	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000458	0.00142	CcSEcCtD
Flucloxacillin—Nervous system disorder—Vincristine—kidney cancer	0.000457	0.00141	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Vincristine—kidney cancer	0.000456	0.00141	CcSEcCtD
Flucloxacillin—Discomfort—Gemcitabine—kidney cancer	0.000455	0.00141	CcSEcCtD
Flucloxacillin—Urticaria—Sorafenib—kidney cancer	0.000455	0.00141	CcSEcCtD
Flucloxacillin—Haematuria—Capecitabine—kidney cancer	0.000454	0.0014	CcSEcCtD
Flucloxacillin—Decreased appetite—Dactinomycin—kidney cancer	0.000453	0.0014	CcSEcCtD
Flucloxacillin—Diarrhoea—Vinblastine—kidney cancer	0.000453	0.0014	CcSEcCtD
Flucloxacillin—Body temperature increased—Sorafenib—kidney cancer	0.000452	0.0014	CcSEcCtD
Flucloxacillin—Abdominal pain—Sorafenib—kidney cancer	0.000452	0.0014	CcSEcCtD
Flucloxacillin—Diarrhoea—Everolimus—kidney cancer	0.000451	0.0014	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Sunitinib—kidney cancer	0.00045	0.00139	CcSEcCtD
Flucloxacillin—Hepatobiliary disease—Capecitabine—kidney cancer	0.00045	0.00139	CcSEcCtD
Flucloxacillin—Vascular purpura—Doxorubicin—kidney cancer	0.000445	0.00138	CcSEcCtD
Flucloxacillin—Agranulocytosis—Capecitabine—kidney cancer	0.000444	0.00137	CcSEcCtD
Flucloxacillin—Dysgeusia—Paclitaxel—kidney cancer	0.000444	0.00137	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Gemcitabine—kidney cancer	0.000442	0.00137	CcSEcCtD
Flucloxacillin—Dizziness—Vinblastine—kidney cancer	0.000438	0.00135	CcSEcCtD
Flucloxacillin—Dizziness—Everolimus—kidney cancer	0.000436	0.00135	CcSEcCtD
Flucloxacillin—Abdominal pain—Sunitinib—kidney cancer	0.000435	0.00135	CcSEcCtD
Flucloxacillin—Body temperature increased—Sunitinib—kidney cancer	0.000435	0.00135	CcSEcCtD
Flucloxacillin—Diarrhoea—Erlotinib—kidney cancer	0.000435	0.00135	CcSEcCtD
Flucloxacillin—Nervous system disorder—Gemcitabine—kidney cancer	0.000433	0.00134	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Gemcitabine—kidney cancer	0.000433	0.00134	CcSEcCtD
Flucloxacillin—Feeling abnormal—Dactinomycin—kidney cancer	0.00043	0.00133	CcSEcCtD
Flucloxacillin—Skin disorder—Gemcitabine—kidney cancer	0.000429	0.00133	CcSEcCtD
Flucloxacillin—Hepatitis—Capecitabine—kidney cancer	0.000427	0.00132	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000426	0.00132	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000424	0.00131	CcSEcCtD
Flucloxacillin—Urinary tract disorder—Capecitabine—kidney cancer	0.000422	0.00131	CcSEcCtD
Flucloxacillin—Hypersensitivity—Sorafenib—kidney cancer	0.000422	0.0013	CcSEcCtD
Flucloxacillin—Vomiting—Vinblastine—kidney cancer	0.000421	0.0013	CcSEcCtD
Flucloxacillin—Dizziness—Erlotinib—kidney cancer	0.000421	0.0013	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Paclitaxel—kidney cancer	0.000421	0.0013	CcSEcCtD
Flucloxacillin—Connective tissue disorder—Capecitabine—kidney cancer	0.00042	0.0013	CcSEcCtD
Flucloxacillin—Vomiting—Everolimus—kidney cancer	0.000419	0.0013	CcSEcCtD
Flucloxacillin—Anaemia—Paclitaxel—kidney cancer	0.000419	0.0013	CcSEcCtD
Flucloxacillin—Urethral disorder—Capecitabine—kidney cancer	0.000419	0.0013	CcSEcCtD
Flucloxacillin—Rash—Everolimus—kidney cancer	0.000416	0.00129	CcSEcCtD
Flucloxacillin—Dermatitis—Everolimus—kidney cancer	0.000415	0.00129	CcSEcCtD
Flucloxacillin—Headache—Vinblastine—kidney cancer	0.000415	0.00128	CcSEcCtD
Flucloxacillin—Angioedema—Paclitaxel—kidney cancer	0.000414	0.00128	CcSEcCtD
Flucloxacillin—Purpura—Doxorubicin—kidney cancer	0.000413	0.00128	CcSEcCtD
Flucloxacillin—Headache—Everolimus—kidney cancer	0.000413	0.00128	CcSEcCtD
Flucloxacillin—Abdominal pain—Dactinomycin—kidney cancer	0.000412	0.00128	CcSEcCtD
Flucloxacillin—Body temperature increased—Dactinomycin—kidney cancer	0.000412	0.00128	CcSEcCtD
Flucloxacillin—Malaise—Paclitaxel—kidney cancer	0.000409	0.00126	CcSEcCtD
Flucloxacillin—Leukopenia—Paclitaxel—kidney cancer	0.000406	0.00126	CcSEcCtD
Flucloxacillin—Hypersensitivity—Sunitinib—kidney cancer	0.000406	0.00126	CcSEcCtD
Flucloxacillin—Decreased appetite—Vincristine—kidney cancer	0.000405	0.00125	CcSEcCtD
Flucloxacillin—Vomiting—Erlotinib—kidney cancer	0.000404	0.00125	CcSEcCtD
Flucloxacillin—Erythema multiforme—Capecitabine—kidney cancer	0.000404	0.00125	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000403	0.00125	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Vincristine—kidney cancer	0.000402	0.00124	CcSEcCtD
Flucloxacillin—Rash—Erlotinib—kidney cancer	0.000401	0.00124	CcSEcCtD
Flucloxacillin—Dermatitis—Erlotinib—kidney cancer	0.000401	0.00124	CcSEcCtD
Flucloxacillin—Headache—Erlotinib—kidney cancer	0.000398	0.00123	CcSEcCtD
Flucloxacillin—Constipation—Vincristine—kidney cancer	0.000398	0.00123	CcSEcCtD
Flucloxacillin—Nausea—Vinblastine—kidney cancer	0.000393	0.00122	CcSEcCtD
Flucloxacillin—Convulsion—Paclitaxel—kidney cancer	0.000393	0.00122	CcSEcCtD
Flucloxacillin—Nausea—Everolimus—kidney cancer	0.000392	0.00121	CcSEcCtD
Flucloxacillin—Diarrhoea—Sorafenib—kidney cancer	0.000392	0.00121	CcSEcCtD
Flucloxacillin—Immune system disorder—Capecitabine—kidney cancer	0.000386	0.00119	CcSEcCtD
Flucloxacillin—Arthralgia—Paclitaxel—kidney cancer	0.000386	0.00119	CcSEcCtD
Flucloxacillin—Myalgia—Paclitaxel—kidney cancer	0.000386	0.00119	CcSEcCtD
Flucloxacillin—Decreased appetite—Gemcitabine—kidney cancer	0.000384	0.00119	CcSEcCtD
Flucloxacillin—Hypersensitivity—Dactinomycin—kidney cancer	0.000384	0.00119	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000383	0.00119	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000381	0.00118	CcSEcCtD
Flucloxacillin—Discomfort—Paclitaxel—kidney cancer	0.000381	0.00118	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Vincristine—kidney cancer	0.000381	0.00118	CcSEcCtD
Flucloxacillin—Dizziness—Sorafenib—kidney cancer	0.000378	0.00117	CcSEcCtD
Flucloxacillin—Constipation—Gemcitabine—kidney cancer	0.000378	0.00117	CcSEcCtD
Flucloxacillin—Nausea—Erlotinib—kidney cancer	0.000378	0.00117	CcSEcCtD
Flucloxacillin—Diarrhoea—Sunitinib—kidney cancer	0.000377	0.00117	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Paclitaxel—kidney cancer	0.00037	0.00114	CcSEcCtD
Flucloxacillin—Abdominal pain—Vincristine—kidney cancer	0.000368	0.00114	CcSEcCtD
Flucloxacillin—Body temperature increased—Vincristine—kidney cancer	0.000368	0.00114	CcSEcCtD
Flucloxacillin—Dysgeusia—Capecitabine—kidney cancer	0.000364	0.00113	CcSEcCtD
Flucloxacillin—Dizziness—Sunitinib—kidney cancer	0.000364	0.00113	CcSEcCtD
Flucloxacillin—Feeling abnormal—Gemcitabine—kidney cancer	0.000364	0.00113	CcSEcCtD
Flucloxacillin—Vomiting—Sorafenib—kidney cancer	0.000364	0.00113	CcSEcCtD
Flucloxacillin—Nervous system disorder—Paclitaxel—kidney cancer	0.000363	0.00112	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Paclitaxel—kidney cancer	0.000362	0.00112	CcSEcCtD
Flucloxacillin—Rash—Sorafenib—kidney cancer	0.000361	0.00112	CcSEcCtD
Flucloxacillin—Dermatitis—Sorafenib—kidney cancer	0.00036	0.00112	CcSEcCtD
Flucloxacillin—Skin disorder—Paclitaxel—kidney cancer	0.000359	0.00111	CcSEcCtD
Flucloxacillin—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000358	0.00111	CcSEcCtD
Flucloxacillin—Headache—Sorafenib—kidney cancer	0.000358	0.00111	CcSEcCtD
Flucloxacillin—Diarrhoea—Dactinomycin—kidney cancer	0.000357	0.0011	CcSEcCtD
Flucloxacillin—Vomiting—Sunitinib—kidney cancer	0.00035	0.00108	CcSEcCtD
Flucloxacillin—Body temperature increased—Gemcitabine—kidney cancer	0.000349	0.00108	CcSEcCtD
Flucloxacillin—Rash—Sunitinib—kidney cancer	0.000347	0.00107	CcSEcCtD
Flucloxacillin—Dermatitis—Sunitinib—kidney cancer	0.000347	0.00107	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Capecitabine—kidney cancer	0.000345	0.00107	CcSEcCtD
Flucloxacillin—Headache—Sunitinib—kidney cancer	0.000345	0.00107	CcSEcCtD
Flucloxacillin—Anaemia—Capecitabine—kidney cancer	0.000344	0.00106	CcSEcCtD
Flucloxacillin—Hypersensitivity—Vincristine—kidney cancer	0.000343	0.00106	CcSEcCtD
Flucloxacillin—Eosinophilia—Doxorubicin—kidney cancer	0.000341	0.00105	CcSEcCtD
Flucloxacillin—Nausea—Sorafenib—kidney cancer	0.00034	0.00105	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000337	0.00104	CcSEcCtD
Flucloxacillin—Malaise—Capecitabine—kidney cancer	0.000335	0.00104	CcSEcCtD
Flucloxacillin—Leukopenia—Capecitabine—kidney cancer	0.000333	0.00103	CcSEcCtD
Flucloxacillin—Vomiting—Dactinomycin—kidney cancer	0.000331	0.00103	CcSEcCtD
Flucloxacillin—Rash—Dactinomycin—kidney cancer	0.000329	0.00102	CcSEcCtD
Flucloxacillin—Nausea—Sunitinib—kidney cancer	0.000327	0.00101	CcSEcCtD
Flucloxacillin—Dyspepsia—Paclitaxel—kidney cancer	0.000326	0.00101	CcSEcCtD
Flucloxacillin—Neutropenia—Doxorubicin—kidney cancer	0.000322	0.000996	CcSEcCtD
Flucloxacillin—Decreased appetite—Paclitaxel—kidney cancer	0.000322	0.000995	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000319	0.000988	CcSEcCtD
Flucloxacillin—Diarrhoea—Vincristine—kidney cancer	0.000319	0.000986	CcSEcCtD
Flucloxacillin—Myalgia—Capecitabine—kidney cancer	0.000317	0.00098	CcSEcCtD
Flucloxacillin—Arthralgia—Capecitabine—kidney cancer	0.000317	0.00098	CcSEcCtD
Flucloxacillin—Constipation—Paclitaxel—kidney cancer	0.000316	0.000979	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000314	0.000973	CcSEcCtD
Flucloxacillin—Discomfort—Capecitabine—kidney cancer	0.000313	0.000968	CcSEcCtD
Flucloxacillin—Nausea—Dactinomycin—kidney cancer	0.00031	0.000958	CcSEcCtD
Flucloxacillin—Dizziness—Vincristine—kidney cancer	0.000308	0.000953	CcSEcCtD
Flucloxacillin—Feeling abnormal—Paclitaxel—kidney cancer	0.000305	0.000943	CcSEcCtD
Flucloxacillin—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000304	0.000941	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000302	0.000936	CcSEcCtD
Flucloxacillin—Diarrhoea—Gemcitabine—kidney cancer	0.000302	0.000935	CcSEcCtD
Flucloxacillin—Renal failure—Doxorubicin—kidney cancer	0.000302	0.000933	CcSEcCtD
Flucloxacillin—Jaundice—Doxorubicin—kidney cancer	0.000299	0.000925	CcSEcCtD
Flucloxacillin—Nervous system disorder—Capecitabine—kidney cancer	0.000298	0.000921	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Capecitabine—kidney cancer	0.000297	0.00092	CcSEcCtD
Flucloxacillin—Vomiting—Vincristine—kidney cancer	0.000296	0.000916	CcSEcCtD
Flucloxacillin—Skin disorder—Capecitabine—kidney cancer	0.000295	0.000912	CcSEcCtD
Flucloxacillin—Urticaria—Paclitaxel—kidney cancer	0.000294	0.000909	CcSEcCtD
Flucloxacillin—Rash—Vincristine—kidney cancer	0.000294	0.000909	CcSEcCtD
Flucloxacillin—Dermatitis—Vincristine—kidney cancer	0.000293	0.000908	CcSEcCtD
Flucloxacillin—Haematuria—Doxorubicin—kidney cancer	0.000293	0.000905	CcSEcCtD
Flucloxacillin—Abdominal pain—Paclitaxel—kidney cancer	0.000292	0.000905	CcSEcCtD
Flucloxacillin—Body temperature increased—Paclitaxel—kidney cancer	0.000292	0.000905	CcSEcCtD
Flucloxacillin—Headache—Vincristine—kidney cancer	0.000292	0.000903	CcSEcCtD
Flucloxacillin—Hepatobiliary disease—Doxorubicin—kidney cancer	0.00029	0.000898	CcSEcCtD
Flucloxacillin—Agranulocytosis—Doxorubicin—kidney cancer	0.000286	0.000886	CcSEcCtD
Flucloxacillin—Vomiting—Gemcitabine—kidney cancer	0.000281	0.000869	CcSEcCtD
Flucloxacillin—Rash—Gemcitabine—kidney cancer	0.000279	0.000862	CcSEcCtD
Flucloxacillin—Dermatitis—Gemcitabine—kidney cancer	0.000278	0.000861	CcSEcCtD
Flucloxacillin—Headache—Gemcitabine—kidney cancer	0.000277	0.000857	CcSEcCtD
Flucloxacillin—Nausea—Vincristine—kidney cancer	0.000277	0.000856	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000277	0.000856	CcSEcCtD
Flucloxacillin—Hepatitis—Doxorubicin—kidney cancer	0.000275	0.000852	CcSEcCtD
Flucloxacillin—Hypersensitivity—Paclitaxel—kidney cancer	0.000273	0.000843	CcSEcCtD
Flucloxacillin—Urinary tract disorder—Doxorubicin—kidney cancer	0.000272	0.000842	CcSEcCtD
Flucloxacillin—Connective tissue disorder—Doxorubicin—kidney cancer	0.000271	0.000838	CcSEcCtD
Flucloxacillin—Urethral disorder—Doxorubicin—kidney cancer	0.00027	0.000836	CcSEcCtD
Flucloxacillin—Dyspepsia—Capecitabine—kidney cancer	0.000267	0.000827	CcSEcCtD
Flucloxacillin—Decreased appetite—Capecitabine—kidney cancer	0.000264	0.000817	CcSEcCtD
Flucloxacillin—Nausea—Gemcitabine—kidney cancer	0.000262	0.000812	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000262	0.000811	CcSEcCtD
Flucloxacillin—Erythema multiforme—Doxorubicin—kidney cancer	0.00026	0.000806	CcSEcCtD
Flucloxacillin—Constipation—Capecitabine—kidney cancer	0.00026	0.000803	CcSEcCtD
Flucloxacillin—Diarrhoea—Paclitaxel—kidney cancer	0.000253	0.000783	CcSEcCtD
Flucloxacillin—Feeling abnormal—Capecitabine—kidney cancer	0.00025	0.000774	CcSEcCtD
Flucloxacillin—Immune system disorder—Doxorubicin—kidney cancer	0.000249	0.00077	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Capecitabine—kidney cancer	0.000248	0.000768	CcSEcCtD
Flucloxacillin—Dizziness—Paclitaxel—kidney cancer	0.000245	0.000757	CcSEcCtD
Flucloxacillin—Urticaria—Capecitabine—kidney cancer	0.000241	0.000746	CcSEcCtD
Flucloxacillin—Abdominal pain—Capecitabine—kidney cancer	0.00024	0.000743	CcSEcCtD
Flucloxacillin—Body temperature increased—Capecitabine—kidney cancer	0.00024	0.000743	CcSEcCtD
Flucloxacillin—Vomiting—Paclitaxel—kidney cancer	0.000235	0.000728	CcSEcCtD
Flucloxacillin—Dysgeusia—Doxorubicin—kidney cancer	0.000235	0.000727	CcSEcCtD
Flucloxacillin—Rash—Paclitaxel—kidney cancer	0.000233	0.000722	CcSEcCtD
Flucloxacillin—Dermatitis—Paclitaxel—kidney cancer	0.000233	0.000721	CcSEcCtD
Flucloxacillin—Headache—Paclitaxel—kidney cancer	0.000232	0.000717	CcSEcCtD
Flucloxacillin—Hypersensitivity—Capecitabine—kidney cancer	0.000224	0.000692	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Doxorubicin—kidney cancer	0.000222	0.000688	CcSEcCtD
Flucloxacillin—Anaemia—Doxorubicin—kidney cancer	0.000222	0.000686	CcSEcCtD
Flucloxacillin—Nausea—Paclitaxel—kidney cancer	0.00022	0.00068	CcSEcCtD
Flucloxacillin—Malaise—Doxorubicin—kidney cancer	0.000216	0.000669	CcSEcCtD
Flucloxacillin—Leukopenia—Doxorubicin—kidney cancer	0.000215	0.000664	CcSEcCtD
Flucloxacillin—Convulsion—Doxorubicin—kidney cancer	0.000208	0.000643	CcSEcCtD
Flucloxacillin—Diarrhoea—Capecitabine—kidney cancer	0.000208	0.000643	CcSEcCtD
Flucloxacillin—Arthralgia—Doxorubicin—kidney cancer	0.000204	0.000632	CcSEcCtD
Flucloxacillin—Myalgia—Doxorubicin—kidney cancer	0.000204	0.000632	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000203	0.000627	CcSEcCtD
Flucloxacillin—Discomfort—Doxorubicin—kidney cancer	0.000202	0.000624	CcSEcCtD
Flucloxacillin—Dizziness—Capecitabine—kidney cancer	0.000201	0.000621	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Doxorubicin—kidney cancer	0.000196	0.000606	CcSEcCtD
Flucloxacillin—Vomiting—Capecitabine—kidney cancer	0.000193	0.000597	CcSEcCtD
Flucloxacillin—Nervous system disorder—Doxorubicin—kidney cancer	0.000192	0.000594	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Doxorubicin—kidney cancer	0.000192	0.000593	CcSEcCtD
Flucloxacillin—Rash—Capecitabine—kidney cancer	0.000191	0.000592	CcSEcCtD
Flucloxacillin—Dermatitis—Capecitabine—kidney cancer	0.000191	0.000592	CcSEcCtD
Flucloxacillin—Headache—Capecitabine—kidney cancer	0.00019	0.000589	CcSEcCtD
Flucloxacillin—Skin disorder—Doxorubicin—kidney cancer	0.00019	0.000588	CcSEcCtD
Flucloxacillin—Nausea—Capecitabine—kidney cancer	0.00018	0.000558	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000178	0.000552	CcSEcCtD
Flucloxacillin—Dyspepsia—Doxorubicin—kidney cancer	0.000172	0.000533	CcSEcCtD
Flucloxacillin—Decreased appetite—Doxorubicin—kidney cancer	0.00017	0.000526	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000169	0.000523	CcSEcCtD
Flucloxacillin—Constipation—Doxorubicin—kidney cancer	0.000167	0.000518	CcSEcCtD
Flucloxacillin—Feeling abnormal—Doxorubicin—kidney cancer	0.000161	0.000499	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Doxorubicin—kidney cancer	0.00016	0.000495	CcSEcCtD
Flucloxacillin—Urticaria—Doxorubicin—kidney cancer	0.000155	0.000481	CcSEcCtD
Flucloxacillin—Abdominal pain—Doxorubicin—kidney cancer	0.000155	0.000479	CcSEcCtD
Flucloxacillin—Body temperature increased—Doxorubicin—kidney cancer	0.000155	0.000479	CcSEcCtD
Flucloxacillin—Hypersensitivity—Doxorubicin—kidney cancer	0.000144	0.000446	CcSEcCtD
Flucloxacillin—Diarrhoea—Doxorubicin—kidney cancer	0.000134	0.000414	CcSEcCtD
Flucloxacillin—Dizziness—Doxorubicin—kidney cancer	0.000129	0.0004	CcSEcCtD
Flucloxacillin—Vomiting—Doxorubicin—kidney cancer	0.000124	0.000385	CcSEcCtD
Flucloxacillin—Rash—Doxorubicin—kidney cancer	0.000123	0.000382	CcSEcCtD
Flucloxacillin—Dermatitis—Doxorubicin—kidney cancer	0.000123	0.000381	CcSEcCtD
Flucloxacillin—Headache—Doxorubicin—kidney cancer	0.000123	0.000379	CcSEcCtD
Flucloxacillin—Nausea—Doxorubicin—kidney cancer	0.000116	0.00036	CcSEcCtD
